FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2164126147> ?p ?o ?g. }

• W2164126147 endingPage "143" @default.
• W2164126147 startingPage "127" @default.
• W2164126147 abstract "The World Health Organization's Disability Assessment Scale II (WHO-DAS II) is a generic health-status instrument that provides six domain scores and a total, aggregate score. Two of the domain scores, communication and participation, and the total score, have good validity, internal-consistency reliability, and test-retest stability in individuals with adult-onset hearing loss. As such, these two domain scores and the total WHO-DAS II score may be useful as generic outcome measures to assess the effectiveness of hearing aid intervention for this population. Before the use of the WHO-DAS II in hearing aid clinical trials, however, the responsiveness of the instrument and the short- and long-term outcomes to hearing aid intervention had to be determined. Responsiveness and outcomes were assessed in 380 veterans (approximately half received hearing aids and half served as controls) by examining group differences, effect-size estimates, and individual differences as a function of hearing aid intervention. For comparison, data also were obtained on two disease-specific measures, the APHAB and the HHIE. The WHO-DAS II communication domain and total scores were sufficiently responsive to hearing aid intervention for use in future studies in which group differences are to be detected. The WHO-DAS II participation domain was not sufficiently responsive to hearing aid intervention. The APHAB and HHIE, both disease-specific measures, were more sensitive to hearing aid intervention than the generic measure. The short- and long-term outcomes of hearing aid intervention were also examined in the present study. Group outcomes for hearing aid intervention can be expected to be stable for at least 6 months when measured by WHO-DAS II total score and for at least 12 months when measured by the WHO-DAS II communication domain scores. Effect-size estimates and examination of the number of individuals exhibiting change scores exceeding 90% critical differences for true changes in scores indicate that for clinical applications, disease-specific instruments are more useful than the WHO-DAS II. The findings of this study support the use of the WHO-DAS II as a generic measure in hearing aid trials research so as to allow for comparisons of health-status outcomes across different diseases or disorders." @default.
• W2164126147 created "2016-06-24" @default.
• W2164126147 creator A5002083105 @default.
• W2164126147 creator A5006118112 @default.
• W2164126147 creator A5035034870 @default.
• W2164126147 creator A5050254542 @default.
• W2164126147 creator A5077149161 @default.
• W2164126147 date "2005-01-01" @default.
• W2164126147 modified "2023-10-15" @default.
• W2164126147 title "The WHO-DAS II: Measuring Outcomes of Hearing Aid Intervention for Adults" @default.
• W2164126147 cites W1540549576 @default.
• W2164126147 cites W1847168837 @default.
• W2164126147 cites W1972684094 @default.
• W2164126147 cites W1977339990 @default.
• W2164126147 cites W1984045421 @default.
• W2164126147 cites W1986087616 @default.
• W2164126147 cites W1989842454 @default.
• W2164126147 cites W2003697065 @default.
• W2164126147 cites W2005502233 @default.
• W2164126147 cites W2008854521 @default.
• W2164126147 cites W2010202334 @default.
• W2164126147 cites W2018968507 @default.
• W2164126147 cites W2021501756 @default.
• W2164126147 cites W2021729626 @default.
• W2164126147 cites W2026375596 @default.
• W2164126147 cites W2033035146 @default.
• W2164126147 cites W2034678680 @default.
• W2164126147 cites W2037377025 @default.
• W2164126147 cites W2040638539 @default.
• W2164126147 cites W2041455879 @default.
• W2164126147 cites W2048747620 @default.
• W2164126147 cites W2058161128 @default.
• W2164126147 cites W2059642721 @default.
• W2164126147 cites W2064702480 @default.
• W2164126147 cites W2065840143 @default.
• W2164126147 cites W2089104304 @default.
• W2164126147 cites W2100200845 @default.
• W2164126147 cites W2103971370 @default.
• W2164126147 cites W2113337036 @default.
• W2164126147 cites W2117335350 @default.
• W2164126147 cites W2119722234 @default.
• W2164126147 cites W2120478522 @default.
• W2164126147 cites W2121764267 @default.
• W2164126147 cites W2122290481 @default.
• W2164126147 cites W2148080316 @default.
• W2164126147 cites W2167311298 @default.
• W2164126147 cites W2170766959 @default.
• W2164126147 cites W2328967061 @default.
• W2164126147 cites W2401139431 @default.
• W2164126147 cites W2411439819 @default.
• W2164126147 cites W2417613671 @default.
• W2164126147 cites W2473786944 @default.
• W2164126147 cites W45713180 @default.
• W2164126147 doi "https://doi.org/10.1177/108471380500900304" @default.
• W2164126147 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4111523" @default.
• W2164126147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16244759" @default.
• W2164126147 hasPublicationYear "2005" @default.
• W2164126147 type Work @default.
• W2164126147 sameAs 2164126147 @default.
• W2164126147 citedByCount "67" @default.
• W2164126147 countsByYear W21641261472012 @default.
• W2164126147 countsByYear W21641261472013 @default.
• W2164126147 countsByYear W21641261472014 @default.
• W2164126147 countsByYear W21641261472015 @default.
• W2164126147 countsByYear W21641261472016 @default.
• W2164126147 countsByYear W21641261472017 @default.
• W2164126147 countsByYear W21641261472018 @default.
• W2164126147 countsByYear W21641261472019 @default.
• W2164126147 countsByYear W21641261472021 @default.
• W2164126147 countsByYear W21641261472022 @default.
• W2164126147 countsByYear W21641261472023 @default.
• W2164126147 crossrefType "journal-article" @default.
• W2164126147 hasAuthorship W2164126147A5002083105 @default.
• W2164126147 hasAuthorship W2164126147A5006118112 @default.
• W2164126147 hasAuthorship W2164126147A5035034870 @default.
• W2164126147 hasAuthorship W2164126147A5050254542 @default.
• W2164126147 hasAuthorship W2164126147A5077149161 @default.
• W2164126147 hasBestOaLocation W21641261471 @default.
• W2164126147 hasConcept C118552586 @default.
• W2164126147 hasConcept C2780493683 @default.
• W2164126147 hasConcept C2780665704 @default.
• W2164126147 hasConcept C2780801066 @default.
• W2164126147 hasConcept C2908647359 @default.
• W2164126147 hasConcept C548259974 @default.
• W2164126147 hasConcept C71924100 @default.
• W2164126147 hasConcept C99454951 @default.
• W2164126147 hasConceptScore W2164126147C118552586 @default.
• W2164126147 hasConceptScore W2164126147C2780493683 @default.
• W2164126147 hasConceptScore W2164126147C2780665704 @default.
• W2164126147 hasConceptScore W2164126147C2780801066 @default.
• W2164126147 hasConceptScore W2164126147C2908647359 @default.
• W2164126147 hasConceptScore W2164126147C548259974 @default.
• W2164126147 hasConceptScore W2164126147C71924100 @default.
• W2164126147 hasConceptScore W2164126147C99454951 @default.
• W2164126147 hasIssue "3" @default.
• W2164126147 hasLocation W21641261471 @default.
• W2164126147 hasLocation W21641261472 @default.
• W2164126147 hasLocation W21641261473 @default.

• next